How fast and how often: The pharmacokinetics of drug use are decisive in addiction

Neuroscience and Biobehavioral Reviews

Volumn 56, Issue , 2015, Pages 166-179

  Allain, Florence ^a   Minogianis, Ellie Anna ^a   Roberts, David C S ^b   Samaha, Anne Noël ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Cocaine; Drug addiction; Intermittent drug exposure; Pharmacokinetics; Route of drug intake; Speed of drug delivery

Indexed keywords

COCAINE; DOPAMINE UPTAKE INHIBITOR;

ADAPTATION; BEHAVIOR CHANGE; BRAIN CORTEX; DRUG DEPENDENCE; DRUG EXPOSURE; DRUG FORMULATION; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; DRUG USE; EVOKED RESPONSE; HUMAN; LEGAL LIABILITY; MOTIVATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; ADDICTION; ANIMAL; DRUG ADMINISTRATION ROUTE; PATHOPHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION ROUTES; HUMANS; MOTIVATION; SUBSTANCE-RELATED DISORDERS;

EID: 84937112408     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.06.012     Document Type: Review

References (145)

1. Ahmed S.H. The science of making drug-addicted animals. Neuroscience 2012, 211:107-125.
2. Ahmed S.H., Cador M. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 2006, 31:563-571.
3. Ahmed S.H., Kenny P.J., Koob G.F., Markou A. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 2002, 5:625-626.
4. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
5. Ahmed S.H., Koob G.F. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) 1999, 146:303-312.
6. Ahmed S.H., Koob G.F. Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 2005, 180:473-490.
7. Asan E. Ultrastructural features of tyrosine-hydroxylase-immunoreactive afferents and their targets in the rat amygdala. Cell Tissue Res. 1997, 288:449-469.
8. Baker L.K., Mao D., Chi H., Govind A.P., Vallejo Y.F., Iacoviello M., Herrera S., Cortright J.J., Green W.N., McGehee D.S., Vezina P. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur. J. Neurosci. 2013, 37:1004-1011.
9. Barrio G., De La Fuente L., Lew C., Royuela L., Bravo M.J., Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend. 2001, 63:169-177.
10. Bass C.E., Jansen H.T., Roberts D.C. Free-running rhythms of cocaine self-administration in rats held under constant lighting conditions. Chronobiol. Int. 2010, 27:535-548.
11. Belin D., Balado E., Piazza P.V., Deroche-Gamonet V. Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats. Biol. Psychiatry 2009, 65:863-868.
12. Ben-Shahar O., Ahmed S.H., Koob G.F., Ettenberg A. The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res. 2004, 995:46-54.
13. Benowitz N.L., Henningfield J.E. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N. Engl. J. Med. 1994, 331:123-125.
14. Berlin I., Anthenelli R.M. Monoamine oxidases and tobacco smoking. Int. J. Neuropsychopharmacol. 2001, 4:33-42.
15. Beveridge T.J.R., Wray P., Brewer A., Shapiro B., Mahoney J.J., Newton T.F., Haile C.N., De La Garza R. Analyzing Human Cocaine Use Patterns to Inform Animal Addiction Model Development 2012, College on Problems of Drug Dependence, Palm Springs, CA.
16. Bouayad-Gervais K., Minogianis E.A., Levesque D., Samaha A.N. The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake. Psychopharmacology (Berl) 2014, 231:4241-4252.
17. Brady K.T., Lydiard R.B., Malcolm R., Ballenger J.C. Cocaine-induced psychosis. J. Clin. Psychiatry 1991, 52:509-512.
18. Brebner K., Phelan R., Roberts D.C. Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology (Berl) 2000, 148:314-321.
19. Brown P.L., Kiyatkin E.A. Brain temperature change and movement activation induced by intravenous cocaine delivered at various injection speeds in rats. Psychopharmacology (Berl) 2005, 181:299-308.
20. Budney A.J., Higgins S.T., Bickel W., Kent L. Relationship between intravenous use and achieving initial cocaine abstinence. Drug Alcohol Depend. 1993, 32:133-142.
21. Calipari E.S., Ferris M.J., Siciliano C.A., Zimmer B.A., Jones S.R. Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter. J. Pharmacol. Exp. Ther. 2014, 349:192-198.
22. Calipari E.S., Ferris M.J., Zimmer B.A., Roberts D.C., Jones S.R. Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology 2013, 38:2385-2392.
23. Carey R., Gui J. Cocaine sensitization can accelerate the onset of peak cocaine behavioral effects. Pharmacol. Biochem. Behav. 1998, 60:395-405.
24. Carpenter M.J., Chutuape M.A., Stitzer M.L. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend. 1998, 53:11-15.
25. Cohen A., Koob G.F., George O. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology 2012, 37:2153-2160.
26. Cohen P., Sas A. Cocaine use in amsterdam in non deviant subcultures. Addict. Res. 1994, 2:71-94.
27. Cone E.J. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 1995, 19:459-478.
28. Cone E.J. Recent discoveries in pharmacokinetics of drugs of abuse. Toxicol. Lett. 1998, 102-103:97-101.
29. Connor D.F., Steingard R.J. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential. CNS Drugs 2004, 18:1011-1030.
30. Crombag H.S., Ferrario C.R., Robinson T.E. The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats. Pharmacol. Biochem. Behav. 2008, 90:797-804.
31. Deroche-Gamonet V., Belin D., Piazza P.V. Evidence for addiction-like behavior in the rat. Science 2004, 305:1014-1017.
32. Di Chiara G. Behavioural pharmacology and neurobiology of nicotine reward and dependence. Handbook of Experimental Pharmacology 2000, Springer, Heidelberg. F. Clementi, D. Fornasari, C. Gotti (Eds.).
33. Downs A.W., Eddy N.B. The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 1932, 46:199-200.
34. Eikelboom R., Stewart J. Conditioning of drug-induced physiological responses. Psychol. Rev. 1982, 89:507-528.
35. Espana R.A., Oleson E.B., Locke J.L., Brookshire B.R., Roberts D.C., Jones S.R. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur. J. Neurosci. 2010, 31:336-348.
36. Evans S.M., Cone E.J., Henningfield J.E. Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J. Pharmacol. Exp. Ther. 1996, 279:1345-1356.
37. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol. Psychiatry 2005, 58:751-759.
38. Ferrario C.R., Robinson T.E. Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behavior. Eur. Neuropsychopharmacol. 2007, 17:352-357.
39. Ferrario C.R., Shou M., Samaha A.N., Watson C.J., Kennedy R.T., Robinson T.E. The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum. Brain Res. 2008, 1209:151-156.
40. Ferri C.P., Gossop M. Route of cocaine administration: patterns of use and problems among a Brazilian sample. Addict. Behav. 1999, 24:815-821.
41. Fitch T.E., Roberts D.C. The effects of dose and access restrictions on the periodicity of cocaine self-administration in the rat. Drug Alcohol Depend. 1993, 33:119-128.
42. Fumagalli F., Di Pasquale L., Caffino L., Racagni G., Riva M.A. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur. J. Neurosci. 2007, 26:2756-2763.
43. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 1991, 251:1580-1586.
44. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch. Gen. Psychiatry 1986, 43:107-113.
45. Gossop M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br. J. Addict. 1992, 87:1527-1536.
46. Gossop M., Griffiths P., Powis B., Strang J. Cocaine: patterns of use, route of administration, and severity of dependence. Br. J. Psychiatry 1994, 164:660-664.
47. Graham D.L., Edwards S., Bachtell R.K., Dileone R.J., Rios M., Self D.W. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 2007, 10:1029-1037.
48. Graham D.L., Krishnan V., Larson E.B., Graham A., Edwards S., Bachtell R.K., Simmons D., Gent L.M., Berton O., Bolanos C.A., DiLeone R.J., Parada L.F., Nestler E.J., Self D.W. Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol. Psychiatry 2009, 65:696-701.
49. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 2003, 23:742-747.
50. Hao Y., Martin-Fardon R., Weiss F. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol. Psychiatry 2010, 68:240-248.
51. Hatsukami D.K., Fischman M.W. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?. JAMA 1996, 276:1580-1588.
52. Hodos W. Progressive ratio as a measure of reward strength. Science 1961, 134:943-944.
53. Hollander J.A., Carelli R.M. Abstinence from cocaine self-administration heightens neural encoding of goal-directed behaviors in the accumbens. Neuropsychopharmacology 2005, 30:1464-1474.
54. Hooks M.S., Duffy P., Striplin C., Kalivas P.W. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl) 1994, 115:265-272.
55. Horger B.A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharm. Biochem. Behav. 1990, 37:707-711.
56. Hughes J.R. Dependence potential and abuse liability of nicotine replacement therapies. Biomed. Pharmacother. 1989, 43:11-17.
57. Im H.I., Hollander J.A., Bali P., Kenny P.J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 2010, 13:1120-1127.
58. Izenwasser S., Cox B.M. Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res. 1990, 531:338-341.
59. Izenwasser S., Cox B.M. Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments. Brain Res. 1992, 573:119-125.
60. Jaffe J.H., Cascella N.G., Kumor K.M., Sherer M.A. Cocaine-induced cocaine craving. Psychopharmacology (Berl) 1989, 97:59-64.
61. Javaid J.I., Fischman M.W., Schuster C.R., Dekirmenjian H., Davis J.M. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 1978, 202:227-228.
62. Javaid J.I., Musa M.N., Fischman M., Schuster C.R., Davis J.M. Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharm. Drug Dispos. 1983, 4:9-18.
63. Jeffcoat A.R., Perez-Reyes M., Hill J.M., Sadler B.M., Cook C.E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab. Dispos. 1989, 17:153-159.
64. Jones R.T. The pharmacology of cocaine smoking in humans. NIDA Res. Monogr. 1990, 99:30-41. Source: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services.
65. Jones S.R., Lee T.H., Wightman R.M., Ellinwood E.H. Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) 1996, 126:331-338.
66. Jonkman S., Pelloux Y., Everitt B.J. Drug intake is sufficient, but conditioning is not necessary for the emergence of compulsive cocaine seeking after extended self-administration. Neuropsychopharmacology 2012, 37:1612-1619.
67. Kato S., Wakasa Y., Yanagita T. Relationship between minimum reinforcing doses and injection speed in cocaine and pentobarbital self-administration in crab-eating monkeys. Pharmacol. Biochem. Behav. 1987, 28:407-410.
68. Kippin T.E., Fuchs R.A., See R.E. Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 2006, 187:60-67.
69. Knackstedt L.A., Kalivas P.W. Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization. J. Pharmacol. Exp. Ther. 2007, 322(3):1103-1109.
70. Kuczenski R., Segal D.S. Psychomotor stimulant-induced sensitization: behavioral and neurochemical correlates. Sensitization in the Nervous System 1988, 175-205. Telford Press, Caldwell, NJ. P.W. Kalivas, C.D. Barnes (Eds.).
71. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berlin) 1989, 98:357-362.
72. Liu Y., Roberts D.C., Morgan D. Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats. Psychopharmacology (Berl) 2005, 179:644-651.
73. Liu Y., Roberts D.C., Morgan D. Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed. Eur. J. Neurosci. 2005, 22:195-200.
74. Loh E.A., Roberts D.C. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berl) 1990, 101:262-266.
75. Lorrain D.S., Arnold G.M., Vezina P. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav. Brain Res. 2000, 107:9-19.
76. Mantsch J.R., Yuferov V., Mathieu-Kia A.M., Ho A., Kreek M.J. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology (Berl) 2004, 175:26-36.
77. Martin-Garcia E., Courtin J., Renault P., Fiancette J.F., Wurtz H., Simonnet A., Levet F., Herry C., Deroche-Gamonet V. Frequency of cocaine self-administration influences drug seeking in the rat: optogenetic evidence for a role of the prelimbic cortex. Neuropsychopharmacology 2014, 39(10):2317-2330.
78. Mendrek A., Blaha C.D., Phillips A.G. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology (Berl) 1998, 135:416-422.
79. Minogianis E.A., Levesque D., Samaha A.N. The speed of cocaine delivery determines the subsequent motivation to self-administer the drug. Neuropsychopharmacology 2013, 38(13):2644-2656.
80. Morgan D., Brebner K., Lynch W.J., Roberts D.C. Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement. Behav. Pharmacol. 2002, 13:389-396.
81. Morgan D., Liu Y., Roberts D.C. Rapid and persistent sensitization to the reinforcing effects of cocaine. Neuropsychopharmacology 2006, 31:121-128.
82. Morgan D., Roberts D.C. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration. Neurosci. Biobehav. Rev. 2004, 27:803-812.
83. Morgan D., Smith M.A., Roberts D.C. Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology (Berl) 2005, 178:309-316.
84. Negus S.S., Henningfield J. Agonist medications for the treatment of cocaine use disorder. Neuropsychopharmacology 2015, (Epub).
85. Neugebauer N.M., Cortright J.J., Sampedro G.R., Vezina P. Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli. Behav. Brain Res. 2014, 260:155-161.
86. Nicola S.M., Deadwyler S.A. Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement. J. Neurosci. 2000, 20:5526-5537.
87. Nomikos G.G., Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl) 1988, 94:119-125.
88. O'Brien C. Drug Addiction and Drug Dependence, Goodman and Gilman's: The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York, NY. 10th ed.
89. O'Brien C.P. Review. Evidence-based treatments of addiction. Philos. Trans. R. Soc. London, Ser., B: Biol. Sci. 2008, 363:3277-3286.
90. O'Brien C.P., Childress A.R., McLellan A.T., Ehrman R. Classical conditioning in drug-dependent humans. Ann. N.Y. Acad. Sci. 1992, 654:400-415.
91. Oleson E.B., Roberts D.C. Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake. Neuropsychopharmacology 2009, 34:796-804.
92. Pan H.T., Menacherry S., Justice J.B. Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J. Neurochem. 1991, 56:1299-1306.
93. Paterson N.E., Markou A. Increased motivation for self-administered cocaine after escalated cocaine intake. NeuroReport 2003, 14:2229-2232.
94. Phillips A.G., Di Ciano P. Behavioral sensitization is induced by intravenous self-administration of cocaine by rats. Psychopharmacology (Berl) 1996, 124:279-281.
95. Piazza P.V., Deminière J.M., Le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 1990, 514:22-26.
96. Pickens R., Thompson T. Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size. J. Pharmacol. Exp. Ther. 1968, 161:122-129.
97. Pierre P.J., Vezina P. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl) 1997, 129:277-284.
98. Pierre P.J., Vezina P. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug. Psychopharmacology (Berl) 1998, 138:159-166.
99. Porrino L.J. Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology (Berl) 1993, 112:343-351.
100. Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci. 1980, 26:1275-1282.
101. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
102. Rawson R.A., Gonzales R., Marinelli-Casey P., Ang A. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am. J. Addict. 2007, 16:291-299.
103. Reith M.E., Benuck M., Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 1987, 243:281-287.
104. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 1996, 66:1-11.
105. Roberts D.C. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 1989, 32:43-47.
106. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) 1989, 98:408-411.
107. Roberts D.C., Brebner K., Vincler M., Lynch W.J. Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend. 2002, 67:291-299.
108. Roberts D.C., Gabriele A., Zimmer B.A. Conflation of cocaine seeking and cocaine taking responses in IV self-administration experiments in rats: methodological and interpretational considerations. Neurosci. Biobehav. Rev. 2013, 37:2026-2036.
109. Roberts D.C., Loh E.A., Baker G.B., Vickers G. Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol. Biochem. Behav. 1994, 49:177-182.
110. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986, 396:157-198.
111. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
112. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000, 95(Suppl. 2):S91-S117.
113. Roncero C., Ros-Cucurull E., Daigre C., Casas M. Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Esp. Psiquiatr. 2012, 40:187-197.
114. Russell M.A., Feyerabend C. Cigarette smoking: a dependence on high-nicotine boli. Drug Metab. Rev. 1978, 8:29-57.
115. Samaha A.N., Li Y., Robinson T.E. The rate of intravenous cocaine administration determines susceptibility to sensitization. J. Neurosci. 2002, 22:3244-3250.
116. Samaha A.N., Mallet N., Ferguson S.M., Gonon F., Robinson T.E. The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J. Neurosci. 2004, 24:6362-6370.
117. Samaha A.N., Yau W.Y., Yang P., Robinson T.E. Rapid delivery of nicotine promotes behavioral sensitization and alters its neurobiological impact. Biol. Psychiatry 2005, 57:351-360.
118. Schindler C.W., Cogan E.S., Thorndike E.B., Panlilio L.V. Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli. Pharmacol. Biochem. Behav. 2011, 99:301-306.
119. Schindler C.W., Panlilio L.V., Thorndike E.B. Effect of rate of delivery of intravenous cocaine on self-administration in rats. Pharmacol. Biochem. Behav. 2009, 93:375-381.
120. Segal D.S., Geyer M.A., Schuckit M.A. Stimulant-induced psychosis: an evaluation of animal models. Essays Neurochem. Neuropharmacol. 1981, 5:95-129.
121. Siegel S. Learning and psychopharmacology. Psychopharmacology in the Practice of Medicine 1977, Appleton-Century-Crofts, New York, NY. M.E. Jarvik (Ed.).
122. Sorge R.E., Clarke P.B. Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists. J. Pharmacol. Exp. Ther. 2009, 330:633-640.
123. Spencer T.J., Biederman J., Ciccone P.E., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., Parasrampuria D.A., Fischman A.J. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am. J. Psychiatry 2006, 163:387-395.
124. Spyraki C., Fibiger H.C., Phillips A.G. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 1982, 253:195-203.
125. Spyraki C., Nomikos G.G., Varonos D.D. Intravenous cocaine-induced place preference: attenuation by haloperidol. Behav. Brain Res. 1987, 26:57-62.
126. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 1993, 4:289-312.
127. Unterwald E.M., Kreek M.J., Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res. 2001, 900:103-109.
128. Van Dyke C., Barash P.G., Jatlow P., Byck R. Cocaine: plasma concentrations after intranasal application in man. Science 1976, 191:859-861.
129. Van Dyke C., Byck R. Cocaine. Sci. Am. 1982, 246:128-141.
130. Vanderschuren L.J., Everitt B.J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 2004, 305:1017-1019.
131. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 2004, 27:827-839.
132. Vezina P., Lorrain D.S., Arnold G.M., Austin J.D., Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J. Neurosci. 2002, 22:4654-4662.
133. Vezina P., McGehee D.S., Green W.N. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1625-1638.
134. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 2003, 160:1909-1918.
135. Volkow N.D., Wang G.J., Fischman M.W., Foltin R., Fowler J.S., Franceschi D., Franceschi M., Logan J., Gatley S.J., Wong C., Ding Y.S., Hitzemann R., Pappas N. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 2000, 67:1507-1515.
136. Wakabayashi K.T., Weiss M.J., Pickup K.N., Robinson T.E. Rats markedly escalate their intake and show a persistent susceptibility to reinstatement only when cocaine is injected rapidly. J. Neurosci. 2010, 30:11346-11355.
137. Ward A.S., Haney M., Fischman M.W., Foltin R.W. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl) 1997, 132:375-381.
138. Wee S., Mandyam C.D., Lekic D.M., Koob G.F. Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur. Neuropsychopharmacol. 2008, 18:303-311.
139. Willuhn I., Burgeno L.M., Groblewski P.A., Phillips P.E. Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat. Neurosci. 2014, 17:704-709.
140. Wilson M.C., Hitomi M., Schuster C.R. Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey. Psychopharmacologia 1971, 22:271-281.
141. Winger G., Hofmann G.G., Woods J.H. A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects 1992, Oxford UP, New York, PL.
142. Wise R.A., Newton P., Leeb K., Burnette B., Pocock D., Justice J.B. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 1995, 120:10-20.
143. Woolverton W.L., Wang Z. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine. Eur. J. Pharmacol. 2004, 486:251-257.
144. Zernig G. Rate of rise in brain concentration determines reinforcing strength of cocaine in only 63% of tested rats. NIDA Res. Monogr. 1997, 178:218.
145. Zimmer B.A., Oleson E.B., Roberts D.C. The motivation to self-administer is increased after a history of spiking brain levels of cocaine. Neuropsychopharmacology 2012, 37:1901-1910.